CardioComm Solutions, Inc. (USD) CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada, specializes in developing advanced technological solutions for cardiac monitoring. The company delivers both sophisticated software and hardware products, as well as core laboratory reading services, specifically designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems. These comprehensive offerings cater to both the medical sector and individual consumers across the globe. At the heart of CardioComm's operations is proprietary technology that underpins the entire ECG workflow: from initial recording and seamless transmission to detailed viewing, in-depth analysis, comprehensive reporting, and secure long-term storage. This end-to-end capability is crucial for the effective screening, accurate diagnosis, and ongoing management of cardiac patients. Their unique device connectivity and ECG management platforms are integrated into diverse solutions, spanning general medical applications, consumer-grade health products, clinical research initiatives, and modern telemedicine services. The company's extensive software suite includes the Global ECG Management System (GEMS) for cardiac event monitoring, GlobalCardio 12 Lead—a web-enabled and EMR-compatible ECG device—and GEMS Lite for Windows, an electronic system for receiving ECG data. Complementary software modules further enhance their offerings, such as GEMS WIN Air for live wireless ECG monitoring, AutoAttendant to empower healthcare providers by automating routine tasks, and the GEMS HL7 Interface, which ensures compliant data exchange with other EMR systems. Additionally, GlobalCardio EMR integration facilitates the bi-directional transfer of crucial information, including patient data, reports, and related links. Beyond software, CardioComm provides a range of hardware products. These include the portable HeartCheck PEN and HeartCheck handheld ECG monitors, various Sirona telephonic and wireless event recorders, and the HeartCheck CardiBeat device. Furthermore, the company offers Application Service Provider (ASP) solutions, notably C4 ECG management services and HeartCheck SMART Monitoring. Their broader product portfolio also features GlobalCardio 3 Lead, the ECG Viewer SDK, QRS Diagnostic, and QRS 12 Lead Universal.

CardioComm Solutions, Inc. (USD) Active

18 Wynford Drive, Toronto, ON, CA, M3C 3S2

Stock Price USD

Price Change

Last Dividend USD

EKGGF's stock peer is CNNA (Cann American Corp.)

EKGGF's stock peer is CTVEF (Certive Solutions Inc.)

EKGGF's stock peer is DTRK (DATATRAK International, Inc.)

EKGGF's stock peer is ICCO (InterCare DX, Inc.)

EKGGF's stock peer is MDGP (Medgroup Inc.)

EKGGF's stock peer is MITI (Mitesco, Inc.)

EKGGF's stock peer is MJARF (MJardin Group, Inc.)

EKGGF's stock peer is MODVQ (ModivCare Inc.)

EKGGF's stock peer is SMAS (Somatic Systems, Inc.)

EKGGF's stock peer is SZLSF (StageZero Life Sciences Ltd.)

Healthcare Medical - Healthcare Information Services

CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada, specializes in developing advanced technological solutions for cardiac monitoring. The company delivers both sophisticated software and hardware products, as well as core laboratory reading services, specifically designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems. These comprehensive offerings cater to both the medical sector and individual consumers across the globe. At the heart of CardioComm's operations is proprietary technology that underpins the entire ECG workflow: from initial recording and seamless transmission to detailed viewing, in-depth analysis, comprehensive reporting, and secure long-term storage. This end-to-end capability is crucial for the effective screening, accurate diagnosis, and ongoing management of cardiac patients. Their unique device connectivity and ECG management platforms are integrated into diverse solutions, spanning general medical applications, consumer-grade health products, clinical research initiatives, and modern telemedicine services. The company's extensive software suite includes the Global ECG Management System (GEMS) for cardiac event monitoring, GlobalCardio 12 Lead—a web-enabled and EMR-compatible ECG device—and GEMS Lite for Windows, an electronic system for receiving ECG data. Complementary software modules further enhance their offerings, such as GEMS WIN Air for live wireless ECG monitoring, AutoAttendant to empower healthcare providers by automating routine tasks, and the GEMS HL7 Interface, which ensures compliant data exchange with other EMR systems. Additionally, GlobalCardio EMR integration facilitates the bi-directional transfer of crucial information, including patient data, reports, and related links. Beyond software, CardioComm provides a range of hardware products. These include the portable HeartCheck PEN and HeartCheck handheld ECG monitors, various Sirona telephonic and wireless event recorders, and the HeartCheck CardiBeat device. Furthermore, the company offers Application Service Provider (ASP) solutions, notably C4 ECG management services and HeartCheck SMART Monitoring. Their broader product portfolio also features GlobalCardio 3 Lead, the ECG Viewer SDK, QRS Diagnostic, and QRS 12 Lead Universal.

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Recent News

CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration

Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a provider of consumer heart monitoring, remote patient monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it has entered into a strategic collaboration, joint development and intellectual property agreement with Predictiv AI Inc. ("Predictiv AI") of North York, Ontario. The agreement establishes a framework under which the companies may identify, assess and, where mutually approved, pursue specific projects involving healthcare software, medical software, artificial intelligence, automated analytics, remote patient monitoring, clinical decision support, biosignal interpretation, predictive analytics, workflow optimization and software as a medical device applications.

2026-06-08 09:11:00

CardioComm Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933

Toronto, Ontario--(Newsfile Corp. - May 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leader in consumer heart monitoring, remote patient monitoring, and medical electrocardiogram ("ECG") software solutions, announces that it has elected to rely on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-933 allows eligible venture issuers listed on the TSX Venture Exchange (the "TSXV") to voluntarily move from a quarterly to a semi-annual financial reporting framework.

2026-05-08 16:01:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions